{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:52:29Z","timestamp":1792101149170,"version":"4.4.0"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Dermatol"],"published-print":{"date-parts":[[2018]]},"DOI":"10.4103\/ijd.ijd_582_17","type":"journal-article","created":{"date-parts":[[2018,2,13]],"date-time":"2018-02-13T01:56:24Z","timestamp":1518486984000},"page":"30","source":"Crossref","is-referenced-by-count":98,"title":["Drug reaction with eosinophilia and systemic symptoms: An update and review of recent literature"],"prefix":"10.4103","volume":"63","author":[{"given":"Abhishek","family":"De","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murlidhar","family":"Rajagopalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarti","family":"Sarda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudip","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Projna","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0019-5154.225319-1","unstructured":"French LE, Prins C. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis. In: Bolognia JL, Jorrizo JL, Schaffer JV, editors. Dermatology. 3rd ed., Vol. 3. New York: Elsevier; 2013. p. 319-34."},{"key":"key-10.4103\/0019-5154.225319-2","first-page":"693","volume-title":"DRESS syndrome: Part I.Clinical perspectives","author":"Husain","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0019-5154.225319-3","first-page":"897","volume-title":"Dilantin sensitivity; Report of a case of hepatitis with jaundice, pyrexia and exfoliative dermatitis","author":"Chaiken","year":"1950","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0019-5154.225319-4","first-page":"874","volume-title":"DIDMOHS: A proposed consensus nomenclature for the drug-induced delayed multiorgan hypersensitivity syndrome","author":"Sontheimer","year":"1998","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0019-5154.225319-5","first-page":"164","volume-title":"Lymphadenopathy induced by anticonvulsant drugs and mimicking clinically pathologically malignant lymphomas","author":"Saltzstein","year":"1959","journal-title":"Cancer"},{"key":"key-10.4103\/0019-5154.225319-6","first-page":"1826","volume-title":"Anticonvulsant hypersensitivity syndrome.In vitro assessment of risk","author":"Shear","year":"1988","journal-title":"J Clin Invest"},{"key":"key-10.4103\/0019-5154.225319-7","first-page":"357","volume-title":"The drug hypersensitivity syndrome: What is the pathogenesis?","author":"Sullivan","year":"2001","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0019-5154.225319-8","first-page":"489","volume-title":"Anticonvulsant hypersensitivity syndrome: Incidence, prevention and management","author":"Knowles","year":"1999","journal-title":"Drug Saf"},{"key":"key-10.4103\/0019-5154.225319-9","first-page":"250","volume-title":"Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug rash with eosinophilia and systemic symptoms: DRESS)","author":"Bocquet","year":"1996","journal-title":"Semin Cutan Med Surg"},{"key":"key-10.4103\/0019-5154.225319-10","first-page":"363","volume-title":"Drug-induced hypersensitivity syndrome in Japan in the past 10 years based on data from the relief system of the Pharmaceuticals and Medical Devices Agency","author":"Kinoshita","year":"2017","journal-title":"Allergol Int"},{"key":"key-10.4103\/0019-5154.225319-11","first-page":"1044","volume-title":"Clinicopathological features and prognosis of drug rash with eosinophilia and systemic symptoms: A study of 30 cases in Taiwan","author":"Chiou","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key-10.4103\/0019-5154.225319-12","first-page":"542","volume-title":"Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: A record linkage study","author":"Tennis","year":"1997","journal-title":"Neurology"},{"key":"key-10.4103\/0019-5154.225319-13","first-page":"947","volume-title":"DRESS syndrome: A practical approach for primary care practitioners","author":"Seth","year":"2008","journal-title":"Clin Pediatr (Phila)"},{"key":"key-10.4103\/0019-5154.225319-14","first-page":"588","volume-title":"The DRESS syndrome: A literature review","author":"Cacoub","year":"2011","journal-title":"Am J Med"},{"key":"key-10.4103\/0019-5154.225319-15","first-page":"15","volume-title":"DRESS syndrome","author":"Descamps","year":"2014","journal-title":"Joint Bone Spine"},{"key":"key-10.4103\/0019-5154.225319-16","first-page":"68","volume-title":"Amoxicillin-induced flare in patients with DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms): Report of seven cases and demonstration of a direct effect of amoxicillin on human herpesvirus 6 replication in vitro","author":"Mardivirin","year":"2010","journal-title":"Eur J Dermatol"},{"key":"key-10.4103\/0019-5154.225319-17","first-page":"1425","volume-title":"Anticonvulsant hypersensitivity syndrome: Implications for pharmaceutical care","author":"Bohan","year":"2007","journal-title":"Pharmacotherapy"},{"key":"key-10.4103\/0019-5154.225319-18","first-page":"853","volume-title":"Carbamazepine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: Report of four cases and brief review","author":"Ganeva","year":"2008","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/0019-5154.225319-19","first-page":"197","volume-title":"Drug rash with eosinophilia and systemic symptoms (DRESS syndrome)","author":"Tas","year":"1999","journal-title":"Acta Clin Belg"},{"key":"key-10.4103\/0019-5154.225319-20","first-page":"683","volume-title":"Human leukocyte antigen genotypes in carbamazepine-induced severe cutaneous adverse drug response in Japanese patients","author":"Kashiwagi","year":"2008","journal-title":"J Dermatol"},{"key":"key-10.4103\/0019-5154.225319-21","first-page":"297","volume-title":"Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions","author":"Hung","year":"2006","journal-title":"Pharmacogenet Genomics"},{"key":"key-10.4103\/0019-5154.225319-22","first-page":"301","volume-title":"Several herpesviruses can reactivate in a severe drug-induced multiorgan reaction in the same sequential order as in graft-versus-host disease","author":"Kano","year":"2006","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0019-5154.225319-23","first-page":"75","volume-title":"Adverse cutaneous drug eruptions: Current understanding","author":"Hoetzenecker","year":"2016","journal-title":"Semin Immunopathol"},{"key":"key-10.4103\/0019-5154.225319-24","first-page":"7","volume-title":"Drug hypersensitivity syndrome","author":"Kumari","year":"2011","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/0019-5154.225319-25","first-page":"67","volume-title":"Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: A cause of unpredictable multiorgan failure","author":"Eshki","year":"2009","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0019-5154.225319-26","first-page":"219","volume-title":"Retrospective analysis of drug-induced hypersensitivity syndrome: A study of 27 patients","author":"Ang","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0019-5154.225319-27","first-page":"49","volume-title":"Is the drug-induced hypersensitivity syndrome (DIHS) due to human herpesvirus 6 infection or to allergy-mediated viral reactivation.Report of a case and literature review?","author":"Gentile","year":"2010","journal-title":"BMC Infect Dis"},{"key":"key-10.4103\/0019-5154.225319-28","first-page":"743","volume-title":"Visceral involvements and long-term sequelae in drug-induced hypersensitivity syndrome","author":"Kano","year":"2010","journal-title":"Med Clin North Am"},{"key":"key-10.4103\/0019-5154.225319-29","first-page":"142","volume-title":"Severe drug-induced skin reactions: Clinical pattern, diagnostics and therapy","author":"Mockenhaupt","year":"2009","journal-title":"J Dtsch Dermatol Ges"},{"key":"key-10.4103\/0019-5154.225319-30","first-page":"5","volume-title":"Twenty cases of DRESS syndrome: Culprits, clinical features, treatment and outcome","author":"Proudfoot","year":"2009","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0019-5154.225319-31","first-page":"481","volume-title":"The variable clinical picture of drug-induced hypersensitivity syndrome\/drug rash with eosinophilia and systemic symptoms in relation to the eliciting drug","author":"Kano","year":"2009","journal-title":"Immunol Allergy Clin North Am"},{"key":"key-10.4103\/0019-5154.225319-32","first-page":"331","volume-title":"Allopurinol hypersensitivity syndrome associated with systemic cytomegalovirus infection and systemic bacteremia","author":"Arakawa","year":"2001","journal-title":"Intern Med"},{"key":"key-10.4103\/0019-5154.225319-33","first-page":"703","volume-title":"Management of drug reaction with eosinophilia and systemic symptoms (DRESS)","author":"Descamps","year":"2010","journal-title":"Ann Dermatol Venereol"},{"key":"key-10.4103\/0019-5154.225319-34","first-page":"391","volume-title":"Patch testing for the diagnosis of anticonvulsant hypersensitivity syndrome: A systematic review","author":"Elzagallaai","year":"2009","journal-title":"Drug Saf"},{"key":"key-10.4103\/0019-5154.225319-35","first-page":"1439","volume-title":"Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: Dependence on its timing and the type of drug eruption","author":"Kano","year":"2007","journal-title":"Allergy"},{"key":"key-10.4103\/0019-5154.225319-36","first-page":"709","volume-title":"DRESS syndrome: Part II.Management and therapeutics","author":"Husain","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0019-5154.225319-37","first-page":"609","volume-title":"Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: Does a DRESS syndrome really exist?","author":"Kardaun","year":"2007","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0019-5154.225319-38","first-page":"1","volume-title":"Drug-induced hypersensitivity syndrome (DIHS): A reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses","author":"Shiohara","year":"2006","journal-title":"Allergol Int"},{"key":"key-10.4103\/0019-5154.225319-39","first-page":"539","volume-title":"Review of drug-induced hypersensitivity: Special emphasis on drug-induced hypersensitivity syndrome","author":"Shiohara","year":"2012","journal-title":"Expert Rev Dermatol"},{"key":"key-10.4103\/0019-5154.225319-40","first-page":"140","volume-title":"The prevalence and risk of immune restoration disease in HIV-infected patients treated with highly active antiretroviral therapy","author":"Jevtovi\u0107","year":"2005","journal-title":"HIV Med"},{"key":"key-10.4103\/0019-5154.225319-41","first-page":"100","volume-title":"High-dose intravenous immunoglobulin monotherapy for drug-induced hypersensitivity syndrome","author":"Kito","year":"2012","journal-title":"Acta Derm Venereol"},{"key":"key-10.4103\/0019-5154.225319-42","first-page":"510","volume-title":"Case reports: Treatment of nevirapine-associated dress syndrome with intravenous immune globulin (IVIG)","author":"Fields","year":"2005","journal-title":"J Drugs Dermatol"},{"key":"key-10.4103\/0019-5154.225319-43","first-page":"E14","volume-title":"Successful treatment of antiepileptic drug hypersensitivity syndrome with intravenous immune globulin","author":"Scheuerman","year":"2001","journal-title":"Pediatrics"},{"key":"key-10.4103\/0019-5154.225319-44","first-page":"543","volume-title":"Poor benefit\/risk balance of intravenous immunoglobulins in DRESS","author":"Joly","year":"2012","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0019-5154.225319-45","first-page":"e11","volume-title":"Cyclophosphamide therapy for corticoresistant drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome in a patient with severe kidney and eye involvement and Epstein-Barr virus reactivation","author":"Laban","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"key-10.4103\/0019-5154.225319-46","first-page":"155","volume-title":"Vancomycin-induced hypersensitivity reaction with acute renal failure: Resolution following cyclosporine treatment","author":"Zuliani","year":"2005","journal-title":"Clin Nephrol"},{"key":"key-10.4103\/0019-5154.225319-47","first-page":"353","volume-title":"Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): An update","author":"Tas","year":"2003","journal-title":"Dermatology"},{"key":"key-10.4103\/0019-5154.225319-48","first-page":"CS57","volume-title":"Treatment of DIHS\/DRESS syndrome with combined N-acetylcysteine, prednisone and valganciclovir \u2013 A hypothesis","author":"Moling","year":"2012","journal-title":"Med Sci Monit"},{"key":"key-10.4103\/0019-5154.225319-49","first-page":"930","volume-title":"Identifying prognostic factors for drug rash with eosinophilia and systemic symptoms (DRESS)","author":"Wei","year":"2011","journal-title":"Eur J Dermatol"},{"key":"key-10.4103\/0019-5154.225319-50","doi-asserted-by":"crossref","unstructured":"Bircher AJ: Symptoms and danger signs in drug hypersensitivity. Toxicology 2005;209:201\u20137.","DOI":"10.1016\/j.tox.2004.12.036"}],"container-title":["Indian Journal of Dermatology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:38:43Z","timestamp":1786714723000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.IJD_582_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018]]}},"alternative-id":["225319"],"URL":"https:\/\/doi.org\/10.4103\/ijd.ijd_582_17","relation":{},"ISSN":["0019-5154"],"issn-type":[{"value":"0019-5154","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}